FIELD: chemistry.
SUBSTANCE: claimed compound can be used in case of diseases and states, such as tinnitus, neuropathic pain and in treatment of Alzheimer's diseases. Method includes stage (1): interaction of 1-amino-1,3,3,5,5-pentamethylcyclohexane with methanesulfonic acid in anisole at temperature from 50°C to 100°C and ratio of anisole volume to weight of 1-amino-1,3,3,5,5-pentamethylcyclohexane from 5 to 15 ml of anisole per gram of 1-amino-1,3,3,5,5-pentamethylcyclohexane. Solvent can contain dissolved in it water. Metod can also include stage (ii): separation of 1-amino-1,3,3,5,5-pentamethylcyclohexane mesylate from reaction mixture of stage (i) by crystallisation with decrease of temperature in the range from -20°C to 50°C. Additionally, after stage (i) or stage (ii), method can include at least one of stages (iii)-(v). Stage (iii) consists in recrystallisation of product, formed at stage (i) or stage (ii) from anisole; stage (iv) includes addition of 1-amino-1,3,3,5,5-pentamethylcyclohexane mesylate at any of preceding stages (i)-(iii); and stage (v) ingludes deagglomeration and/or crushing product, formed at any of preceding stages (i)-(iv). Crystals, obtained at stage (iv) are star-shaped. At stage (ii) or at stage (iv) also obtained are particles of 1-amino-1,3,3,5,5-pentamethylcyclohexane mesylate, where less than 15% in weight of particles have particle size 10 mcm and less or where less than 10% in weight of particles have particle size 10 mcm and less. Before separation of 1-amino-1,3,3,5,5-pentamethylcyclohexane mesylate, mixture, obtained at stage (i), (ii) or (iii), is usually cooled to room temperature or below room temperature at rate of cooling from 0.05°C/min to 2°C/min.
EFFECT: invention relates to improved method of obtaining 1-amino-1,3,3,5,5-pentamethylcyclohexane mesylate.
11 cl, 6 dwg, 2 tbl, 22 ex
Title | Year | Author | Number |
---|---|---|---|
1-AMINOALKYLCYCLOHEXANE DERIVATIVES FOR TREATING AND PREVENTING HEARING LOSS | 2008 |
|
RU2452476C2 |
DERIVATIVES OF 1-AMINO-ALKYLCYCLOHEXANE FOR TREATMENT OF DISEASES, MEDIATED BY MAST CELLS | 2009 |
|
RU2484813C2 |
1-AMINOALKYLCYCLOHEXANE DERIVATIVES FOR TREATING COCHLEAR TINNITUS | 2008 |
|
RU2438658C2 |
INTERVAL THERAPY FOR TREATING TINNITUS | 2008 |
|
RU2446794C2 |
1-AMINOALKYLCYCLOHEXANE DERIVATIVES FOR TREATMENT OF INFLAMMATORY SKIN DISEASES | 2009 |
|
RU2481828C2 |
NERAMEXANE TITRATION KIT AND USING IT IN TREATING INTERNAL EAR DISORDERS | 2008 |
|
RU2459618C2 |
METHOD FOR PREPARING NO-DONOR COMPOUNDS, SUCH AS NO-DONOR DICLOFENAC | 2003 |
|
RU2322434C2 |
HIGH-PURITY QUINOLINE DERIVATIVE AND ITS PRODUCTION METHOD | 2015 |
|
RU2785875C2 |
MATRIX TABLET WITH MODIFIED NERAMEXANE RELEASE | 2006 |
|
RU2422135C2 |
NEW COMBINATIONS OF NERAMEXANE FOR TREATING NEURODEGENERATIVE DISORDERS | 2008 |
|
RU2432161C1 |
Authors
Dates
2014-04-20—Published
2010-04-16—Filed